Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm Philippe Chetaille, Christoph Preuss, Silja Burkhard, Jean Marc Cote, Christine Houde, Julie Castilloux, Jessica Piché, Natacha Gosset, Séverine Leclerc, Florian Wunnemann, et al. To cite this version: Philippe Chetaille, Christoph Preuss, Silja Burkhard, Jean Marc Cote, Christine Houde, et al.. Muta- tions in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm. Nature Genetics, Nature Publishing Group, 2014, 10.1038/ng.3113. hal-02543639 HAL Id: hal-02543639 https://hal.umontpellier.fr/hal-02543639 Submitted on 15 Apr 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. LETTERS Mutations in SGOL1 cause a novel cohesinopathy affecting heart and gut rhythm Philippe Chetaille1,14, Christoph Preuss2,14, Silja Burkhard3,14, Jean-Marc Côté1, Christine Houde1, Julie Castilloux1, Jessica Piché2, Natacha Gosset2, Séverine Leclerc2, Florian Wünnemann2, Maryse Thibeault2, Carmen Gagnon2, Antonella Galli4, Elizabeth Tuck4, Gilles R Hickson5, Nour El Amine5, Ines Boufaied5, Emmanuelle Lemyre5, Pascal de Santa Barbara6, Sandrine Faure6, Anders Jonzon7, Michel Cameron2, Harry C Dietz8, Elena Gallo-McFarlane8, D Woodrow Benson9, Claudia Moreau5, Damian Labuda5, FORGE Canada Consortium10, Shing H Zhan11, Yaoqing Shen 11, Michèle Jomphe12, Steven J M Jones11, Jeroen Bakkers3 & Gregor Andelfinger2,5,13 The pacemaking activity of specialized tissues in the heart (CIPO) is a rare and severe disorder of gastrointestinal motility in and gut results in lifelong rhythmic contractions. Here we which intestinal obstruction occurs in the absence of a mechanical describe a new syndrome characterized by Chronic Atrial obstacle. Several studies identified genetic risk factors for SSS2–8 and and Intestinal Dysrhythmia, termed CAID syndrome, in 16 CIPO9,10, but in most cases the genetic causes remain enigmatic. French Canadians and 1 Swede. We show that a single shared We identified 17 subjects in whom SSS and CIPO co-occurred homozygous founder mutation in SGOL1, a component of the during the first four decades of life (Fig. 1a). Distinctive clinical cohesin complex, causes CAID syndrome. Cultured dermal features included atrial dysrhythmias, SSS and valve anomalies, fibroblasts from affected individuals showed accelerated cell as well as a requirement for pacemaker implantation and total cycle progression, a higher rate of senescence and enhanced parenteral nutrition (Fig. 1b,c and Supplementary Tables 1 and 2). activation of TGF-b signaling. Karyotypes showed the typical In different individuals with CAID, CIPO was found to be of neu- railroad appearance of a centromeric cohesion defect. Tissues rogenic or myogenic origin (Supplementary Fig. 1). No case had Nature America, Inc. All rights reserved. America, Inc. Nature derived from affected individuals displayed pathological 4 clinical evidence of other congenital anomalies or manifestations changes in both the enteric nervous system and smooth of known cohesinopathies. Family evaluation suggested inherit- © 201 muscle. Morpholino-induced knockdown of sgol1 in zebrafish ance in an autosomal recessive manner, prompting us to perform recapitulated the abnormalities seen in humans with CAID whole-exome sequencing of three unrelated probands. We identified syndrome. Our findings identify CAID syndrome as a novel only one homozygous pathogenic variant shared by all probands, generalized dysrhythmia, suggesting a new role for SGOL1 namely, c.67A>G, n.367–2014T>C, in SGOL1 (rs199815268), which npg and the cohesin complex in mediating the integrity of human was predicted to encode a damaging change, p.Lys23Glu, at a highly cardiac and gut rhythm. conserved residue (Supplementary Fig. 2a–c and Supplementary Table 3). The mutation was extremely rare (minor allele frequency Disturbances of pacemaker activity in the heart and gut can have (MAF) < 1%) in public databases11 (see URLs) and was absent in 360 varied clinical manifestations. Dysregulation of the cardiac sinus node French-Canadian control exomes. We confirmed the homozygous results in sick sinus syndrome (SSS), the most common cause of pace- mutation by Sanger sequencing in all 14 surviving French-Canadian maker implantation1. SSS is rare in children and is characterized by cases and the 1 Swedish case (Fig. 1a). The mutation was absent from persistently decreased heart rhythm, episodes of sinoatrial block and/ 11 isolated pediatric SSS cases without CIPO and 43 isolated pediatric or chronotropic incompetence. In the gut, pacemaking is mediated CIPO cases without SSS. through the network of interstitial cells of Cajal and the autonomous To genetically fine map the disease-causing haplotype and exclude enteric nervous system (ENS). Chronic intestinal pseudo-obstruction the presence of copy number variants (CNVs), we performed Illumina 1Department of Pediatrics, Centre Mère Enfants Soleil, Centre Hospitalier de l’Université (CHU) de Québec, Quebec City, Quebec, Canada. 2Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Université de Montréal, Montreal, Quebec, Canada. 3Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, the Netherlands. 4Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK. 5Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada. 6INSERM U1046, Montpellier, France. 7Department of Women’s and Children’s Health, Section for Pediatrics, Astrid Lindgren’s Children’s Hospital, Uppsala University, Uppsala, Sweden. 8Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 9Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. 10Membership of the Steering Committee for the Consortium is given in the Acknowledgments. 11Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada. 12Projet BALSAC, Université du Québec à Chicoutimi, Chicoutimi, Quebec, Canada. 13Department of Biochemistry, Université de Montréal, Montreal, Quebec, Canada. 14These authors contributed equally to this work. Correspondence should be addressed to G.A. ([email protected]). Received 8 April; accepted 11 September; published online 5 October 2014; doi:10.1038/ng.3113 NATURE GENETICS VOLUME 46 | NUMBER 11 | NOVEMBER 2014 1245 LETTERS Figure 1 Synopsis of families and a 1 2 3 4 5 6 b electrocardiographic features. (a) Pedigrees of the CAID syndrome cohort. Wild-type (T/T), T/C T/C T/C T/C T/C T/C T/C T/C heterozygous (T/C) and homozygous (C/C) mutation status are shown. Family and subject numbers refer to those used in the text and 1 2 3 45 6 78 Supplementary Table 2. In family 1, in which T/C C/C C/C C/C C/C T/C C/C T/C C/C C/C the index case was deceased without any available biological material, we found both 7 8 9 10 11 12 parents to be heterozygous for the CAID-linked T/C T/C T/C T/C mutation in SGOL1. (b,c) Evolution of clinical T/C T/C electrocardiographic findings in a CAID case, c showing normal sinus rhythm at 3 years of age (b) and sinus node dysfunction with junctional 9 10 11 12 13 14 15 C/C C/C T/C T/C C/CT/CT/T C/C C/C C/C C/C escape rhythm (40 beats per minute) at 13 14 19 years of age (c). I, II, III, aVR, aVL and aVF T/C T/C denote corresponding peripheral leads. T/C T/C Atrial arrhythmia, SSS or pacemaker CIPO HumanOmni5-Quad genotyping for 13 Valve anomaly cases and 3 unaffected family members. 16 17 Homozygosity mapping with PLINK and C/C HomozygosityMapper12,13 (see URLs) iden- tified a single 1.4-Mb region between SNPs rs2929378 and rs442920 American populations (Supplementary Fig. 4). Reconstitution of harboring SGOL1 that was identical in all the cases (Supplementary ascending genealogies from the BALSAC population database14 for Fig. 3). Further haplotype analysis identified a rare 700-kb disease- 8 French-Canadian cases identified 64 common ancestors married associated haplotype shared by the Swedish and French-Canadian in the seventeenth century in France or in Quebec City. Identity- cases lacking rare CNVs. Genealogy and genetic analyses excluded any by-descent analysis supported the observation that all the French- direct relatedness for the Swedish and French-Canadian individuals Canadian CAID cases derived from the eastern part of Quebec and (PLINK pi-hat < 0.2; F inbreeding coefficient –0.1 –0). Our popula- shared a common ancestral haplotype for SGOL1, whose age was tion genetic analysis determined that the rare disease-causing haplo- estimated at 13 o 4 generations. Allele dropping analysis identified a type was of northern European origin and demonstrated the absence founder couple, married in France in 1620, whose likelihood of being of tagging SNPs for this haplotype in Asian, African and admixed the mutation carriers exceeded that for other founders by a factor Mitosis Senescence WT Proliferation WT c P < 0.01 P < 0.01 d a b TGF- signalling Mut Mut P < 0.05 3.0 P < 0.01 Nature America, Inc. All rights reserved. America, Inc. Nature 2.0 WT WT 4 15 400 P < 0.01 Mut Mut 1.5 2.0 © 201 300 1.0 10 P < 0.01 P < 0.01 Mitotic cells (%) 0.5 NSNS P < 0.01 200 Proliferation index 1.0 0 0 pSMAD2/3 npg WT/WT Mut/Mut 5 100 Senescent cells (%) WT/WT Mut/Mut WT/WT Mut/Mut (mean fluorescence intensity) 24 h 48 h 0 P < 0.05 0 Mock Mock 20 min 60 min 20 min 60 min Figure 2 Cellular phenotypes of CAID.